Vesetumor és vena cava inferior tumorthrombus kezelése.

Translated title of the contribution: [Treatment of renal cell carcinoma associated with vena inferior cava tumor thrombus].

Zoltán Nagy, József Pánovics, László Harsányi, Attila Szendröi, Miklós Szücs, I. Romics

Research output: Contribution to journalArticle

Abstract

Follow-up and review of patients who underwent surgery for renal cell cancer combined with tumor thrombus of the inferior vena cava at the Department of Urology Semmelweis University, Budapest, Hungary. From l998 to 2010 twenty one patients underwent surgery for renal cell cancer combined with tumor thrombus of the inferior caval vein. Preoperative symptoms, TNM classification of the tumors, types of surgical interventions, complications, postoperative management and survival results were involved in the analysis. Mean follow-up period was 39 months, ranging from 3 to 101 months. In five cases of level 3 thrombi the liver was mobilized without thoracotomy, and endoluminar occlusion was applied in one case. Intraoperative mortality was 9,5%. Survival time of patients with distant metastases was 12.1 months (3-9). Three patients without metastases died in the follow up period, their survival time was 26.7 months ranging from 22 to 31 months. Eight patients (73%) were alive at the time of the last follow-up. The mean survival time was 5.6 years ranging from 39 to 101 months. Our results support that level 3 caval vein tumor thrombus can be removed by less aggressive surgical approach and underline the benefit of the surgical intervention without thoracotomy.

Original languageHungarian
Pages (from-to)283-288
Number of pages6
JournalMagyar sebészet
Volume64
Issue number6
Publication statusPublished - Dec 2011

Fingerprint

Inferior Vena Cava
Renal Cell Carcinoma
Thrombosis
Venae Cavae
Thoracotomy
Neoplasms
Survival
Veins
Neoplasm Metastasis
Therapeutics
Hungary
Neoplasm Staging
Urology
Survival Rate
Mortality
Liver

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Nagy, Z., Pánovics, J., Harsányi, L., Szendröi, A., Szücs, M., & Romics, I. (2011). Vesetumor és vena cava inferior tumorthrombus kezelése. Magyar sebészet, 64(6), 283-288.

Vesetumor és vena cava inferior tumorthrombus kezelése. / Nagy, Zoltán; Pánovics, József; Harsányi, László; Szendröi, Attila; Szücs, Miklós; Romics, I.

In: Magyar sebészet, Vol. 64, No. 6, 12.2011, p. 283-288.

Research output: Contribution to journalArticle

Nagy, Z, Pánovics, J, Harsányi, L, Szendröi, A, Szücs, M & Romics, I 2011, 'Vesetumor és vena cava inferior tumorthrombus kezelése.', Magyar sebészet, vol. 64, no. 6, pp. 283-288.
Nagy Z, Pánovics J, Harsányi L, Szendröi A, Szücs M, Romics I. Vesetumor és vena cava inferior tumorthrombus kezelése. Magyar sebészet. 2011 Dec;64(6):283-288.
Nagy, Zoltán ; Pánovics, József ; Harsányi, László ; Szendröi, Attila ; Szücs, Miklós ; Romics, I. / Vesetumor és vena cava inferior tumorthrombus kezelése. In: Magyar sebészet. 2011 ; Vol. 64, No. 6. pp. 283-288.
@article{518422f304344f0a9e10688a4af85fe3,
title = "Vesetumor {\'e}s vena cava inferior tumorthrombus kezel{\'e}se.",
abstract = "Follow-up and review of patients who underwent surgery for renal cell cancer combined with tumor thrombus of the inferior vena cava at the Department of Urology Semmelweis University, Budapest, Hungary. From l998 to 2010 twenty one patients underwent surgery for renal cell cancer combined with tumor thrombus of the inferior caval vein. Preoperative symptoms, TNM classification of the tumors, types of surgical interventions, complications, postoperative management and survival results were involved in the analysis. Mean follow-up period was 39 months, ranging from 3 to 101 months. In five cases of level 3 thrombi the liver was mobilized without thoracotomy, and endoluminar occlusion was applied in one case. Intraoperative mortality was 9,5{\%}. Survival time of patients with distant metastases was 12.1 months (3-9). Three patients without metastases died in the follow up period, their survival time was 26.7 months ranging from 22 to 31 months. Eight patients (73{\%}) were alive at the time of the last follow-up. The mean survival time was 5.6 years ranging from 39 to 101 months. Our results support that level 3 caval vein tumor thrombus can be removed by less aggressive surgical approach and underline the benefit of the surgical intervention without thoracotomy.",
author = "Zolt{\'a}n Nagy and J{\'o}zsef P{\'a}novics and L{\'a}szl{\'o} Hars{\'a}nyi and Attila Szendr{\"o}i and Mikl{\'o}s Sz{\"u}cs and I. Romics",
year = "2011",
month = "12",
language = "Hungarian",
volume = "64",
pages = "283--288",
journal = "Magyar Sebeszet",
issn = "0025-0295",
publisher = "Ifjusagi Lapkiado Vallalat",
number = "6",

}

TY - JOUR

T1 - Vesetumor és vena cava inferior tumorthrombus kezelése.

AU - Nagy, Zoltán

AU - Pánovics, József

AU - Harsányi, László

AU - Szendröi, Attila

AU - Szücs, Miklós

AU - Romics, I.

PY - 2011/12

Y1 - 2011/12

N2 - Follow-up and review of patients who underwent surgery for renal cell cancer combined with tumor thrombus of the inferior vena cava at the Department of Urology Semmelweis University, Budapest, Hungary. From l998 to 2010 twenty one patients underwent surgery for renal cell cancer combined with tumor thrombus of the inferior caval vein. Preoperative symptoms, TNM classification of the tumors, types of surgical interventions, complications, postoperative management and survival results were involved in the analysis. Mean follow-up period was 39 months, ranging from 3 to 101 months. In five cases of level 3 thrombi the liver was mobilized without thoracotomy, and endoluminar occlusion was applied in one case. Intraoperative mortality was 9,5%. Survival time of patients with distant metastases was 12.1 months (3-9). Three patients without metastases died in the follow up period, their survival time was 26.7 months ranging from 22 to 31 months. Eight patients (73%) were alive at the time of the last follow-up. The mean survival time was 5.6 years ranging from 39 to 101 months. Our results support that level 3 caval vein tumor thrombus can be removed by less aggressive surgical approach and underline the benefit of the surgical intervention without thoracotomy.

AB - Follow-up and review of patients who underwent surgery for renal cell cancer combined with tumor thrombus of the inferior vena cava at the Department of Urology Semmelweis University, Budapest, Hungary. From l998 to 2010 twenty one patients underwent surgery for renal cell cancer combined with tumor thrombus of the inferior caval vein. Preoperative symptoms, TNM classification of the tumors, types of surgical interventions, complications, postoperative management and survival results were involved in the analysis. Mean follow-up period was 39 months, ranging from 3 to 101 months. In five cases of level 3 thrombi the liver was mobilized without thoracotomy, and endoluminar occlusion was applied in one case. Intraoperative mortality was 9,5%. Survival time of patients with distant metastases was 12.1 months (3-9). Three patients without metastases died in the follow up period, their survival time was 26.7 months ranging from 22 to 31 months. Eight patients (73%) were alive at the time of the last follow-up. The mean survival time was 5.6 years ranging from 39 to 101 months. Our results support that level 3 caval vein tumor thrombus can be removed by less aggressive surgical approach and underline the benefit of the surgical intervention without thoracotomy.

UR - http://www.scopus.com/inward/record.url?scp=84859899346&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859899346&partnerID=8YFLogxK

M3 - Article

C2 - 22169341

AN - SCOPUS:84859899346

VL - 64

SP - 283

EP - 288

JO - Magyar Sebeszet

JF - Magyar Sebeszet

SN - 0025-0295

IS - 6

ER -